Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.

NCT00314210 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

575

Enrollment

INDUSTRY

Sponsor class

Conditions

Anxiety Disorders

Interventions

DRUG: Quetiapine SR

Sponsor

AstraZeneca